Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
United Kingdom Brexit Regulation

Post-Brexit MHRA Will Embrace Medtech ‘Innovation Pull’ In The UK

Global device networker role, regulatory agility and patient safety prioritized in new chapter for UK regulator

  • News

Executive Summary

The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.

You may also be interested in...



COVID-Delayed UK Medtech Mandate Previews First Products For NHS Adoption

The Medtech Mandate, a scheme that seeks to better match NICE guidance with adoption and use of medtech innovations in the UK, is preparing for launch in April.

Compare And Contrast: New UKCA Marking System Will Stress Safety, Quality And Agility

How UK and EU device regulations will differ in 2021, UK approved bodies and Northern Ireland's unfettered access to the UK market were key themes at the ABHI’s annual regulatory conference.

Solventum: The Identity Of 3M’s Health Care Spin-Off

3M’s health care company spin-off is expected to be launched in the first half of 2024 under the name Solventum. 

Table

View full table

Topics

Tags:
United Kingdom Brexit Regulation
Latest Headlines

Shattered Glass Or Broken Ladder: Is the Medtech Industry Becoming More Equal For Women?

FDA Leaves Global Harmonization Working Party, Will Focus International Harmonization Efforts Elsewhere

Solventum: The Identity Of 3M’s Health Care Spin-Off

Execs On The Move: October 2023

See All
UsernamePublicRestriction

Register

MT143136

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By